We are live on ! Find out more
GEN

Genesis Healthcare, Inc.
GEN

Delisted

GEN was delisted on the 25th of March, 2021.

Back to rankings

55 hedge funds and large institutions have $12.3M invested in Genesis Healthcare, Inc. in 2020 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 3 increasing their positions, 23 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

5% less funds holding

Funds holding: 58 → 55 (-3)

21% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 14

32% less capital invested

Capital invested by funds: $18.1M → $12.3M (-$5.73M)

87% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 23

Holders
55
Holders Change
-3
Holders Change %
-5.17%
% of All Funds
1.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
3
Reduced
23
Closed
14
Calls
$11K
Puts
–
Net Calls
+$11K
Net Calls Change
+$6K

Top Buyers

Rank Fund Capital Flow
1
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$187K
2
Squarepoint
Squarepoint
New York
+$119K
3
First Trust Advisors
First Trust Advisors
Illinois
+$113K
4
VFP
Verus Financial Partners
Virginia
+$28.9K
5
Citadel Advisors
Citadel Advisors
Florida
+$21.8K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$505K
2
Renaissance Technologies
Renaissance Technologies
New York
-$351K
3
Millennium Management
Millennium Management
New York
-$333K
4
VCM
V3 Capital Management
Texas
-$248K
5
OMC
Old Mission Capital
Illinois
-$184K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of America
51
Bank of America
North Carolina
– -$116K -161,012 -100%
Goldman Sachs
52
Goldman Sachs
New York
– -$90K -130,342 Closed
Arrowstreet Capital
53
Arrowstreet Capital
Massachusetts
– -$59K -85,790 Closed
RJA
54
Raymond James & Associates
Florida
– -$38K -55,000 Closed
HF
55
HRT Financial
New York
– -$34K -50,255 Closed
Morgan Stanley
56
Morgan Stanley
New York
– -$29.1K -40,447 -100%
TRCT
57
Tower Research Capital (TRC)
New York
– -$25K -36,094 Closed
GCP
58
GSA Capital Partners
United Kingdom
– -$16K -22,972 Closed
TA
59
Teton Advisors
New York
– -$14K -20,000 Closed
VF
60
Virtu Financial
New York
– -$13K -18,173 Closed
DC
61
Diametric Capital
Massachusetts
– -$13K -18,121 Closed
BCM
62
Bayesian Capital Management
New York
– -$9K -12,832 Closed
PCM
63
Prelude Capital Management
New York
– -$8.85K -12,314 Closed
Russell Investments Group
64
Russell Investments Group
United Kingdom
– -$5K -8,514 Closed
UBS Group
65
UBS Group
Switzerland
– -$126 -175 -37%
Simplex Trading
66
Simplex Trading
Illinois
– +$130 +181 +99%
ETC
67
Exchange Traded Concepts
Oklahoma
– +$229 +318 New
1 2
3

GEN Hedge Fund Activity: Q3 2020 in Review

55 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Genesis Healthcare, Inc. (GEN) for Q3 2020, worth a combined $12.3M — down 32% from $18.1M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of GEN and 11 opened new positions — a net loss of 3 holders — while 23 trimmed existing stakes and 3 added.

The largest buyer was Acadian Asset Management, adding an estimated $187K. The largest seller was Vanguard Group, cutting an estimated $505K.

  • 55 institutional investors held Genesis Healthcare, Inc. (GEN) as of Q3 2020, down from 58 in Q2 2020.
  • Funds reported $12.3M of Genesis Healthcare, Inc. stock for Q3 2020, down 32% quarter-over-quarter.
  • 11 funds opened new Genesis Healthcare, Inc. positions in Q3 2020 and 14 closed out, a net change of -3 holders.
  • The largest Genesis Healthcare, Inc. buyer in Q3 2020 was Acadian Asset Management, an estimated $187K added.
  • The largest Genesis Healthcare, Inc. seller in Q3 2020 was Vanguard Group, an estimated $505K sold.

Based on aggregated 13F filings for Q3 2020.